文献速递细胞病理与分子病理

非妇科细胞病理报告系统在实验室中实施差异很大:2020年CAP补充调查分析

The Implementation of Nongynecologic Reporting Systems in Cytopathology Laboratories Is Highly Variable: Analysis of Data From a 2020 Supplemental Survey of Participants in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology.
PubMed 文献 · Arch Pathol Lab Med · 2024-01-01

该研究基于美国病理学家学会(CAP)非妇科细胞病理教育项目参与者的2020年补充调查,评估常用非妇科报告系统的实施率、实施方法和障碍。结果显示甲状腺Bethesda系统实施率最高(74.1%),其次为巴黎尿细胞学系统(53.9%)和Milan唾液腺系统(29.1%);未采用报告系统的最常见原因是对实验室现有系统满意。结论认为各实验室实施情况差异很大。

要点

  • 甲状腺Bethesda系统实施率74.1%(552/745),为最高。
  • 巴黎尿细胞学系统实施率53.9%(397/736)。
  • Milan唾液腺系统实施率29.1%(200/688)。

核心结论

  • 非妇科细胞病理报告系统在细胞病理实验室中的实施情况高度可变。

研究设计与样本

  • 分析由CAP细胞病理委员会开发并随CAP非妇科细胞病理教育项目邮件发放的调查数据。

主要发现

  • 实施率最高的非妇科报告系统为甲状腺Bethesda系统第二版,74.1%(552/745)。
  • 巴黎尿细胞学报告系统实施率为53.9%(397/736)。
  • Milan唾液腺细胞病理报告系统实施率为29.1%(200/688)。
  • 未采用报告系统的最常见原因是对实验室当前系统满意。
  • 实施情况在各实验室间存在差异,涉及决定实施的利益相关者和实施过程中提供的培训量。

临床怎么用

  • 了解常用非妇科报告系统的实施率有助于实验室评估自身标准化报告实践。
  • 对现有系统满意是未采用新报告系统的主要障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: In recent years, several reporting systems have been developed by national and international cytopathology organizations to standardize the evaluation of specific cytopathology specimen types. OBJECTIVE: To assess the current implementation rates, implementation methods, and barriers to implementation of commonly used nongynecologic reporting systems in cytopathology laboratories. DESIGN: Data were analyzed from a survey developed by the College of American Pathologists Cytopathology Committee and distributed to participants in the College of American Pathologists Nongynecologic Cytopathology Education Program mailing. RESULTS: Nongynecologic reporting systems with the highest rate of adoption were the Bethesda System for Reporting Thyroid Cytopathology, 2nd edition (74.1%; 552 of 745); the Paris System for Reporting Urinary Cytology (53.9%; 397 of 736); and the Milan System for Reporting Salivary Gland Cytopathology (29.1%; 200 of 688). The most common reason given for not adopting a reporting system was satisfaction with a laboratory's current system. Implementation varied among laboratories with regard to which stakeholders were involved in deciding to implement a system and the amount of education provided during the implementation process. CONCLUSIONS: The implementation of nongynecologic reporting systems in cytopathology laboratories was highly variable.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. VandenBussche CJ, Nwosu A, Souers R, et al. The Implementation of Nongynecologic Reporting Systems in Cytopathology Laboratories Is Highly Variable: Analysis of Data From a 2020 Supplemental Survey of Participants in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med. 2024. PMID: 37603681. doi:10.5858/arpa.2023-0010-CP

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。